Global Pharmacovigilance Drug Safety Software Market

Global Pharmacovigilance and Drug Safety Software Market is expected to reach USD 0.42 Bn by 2032 from USD 0.23 Bn in 2025 at CAGR of 9.2%.

To know about the Research Methodology:-Request Free Sample Report

Global Pharmacovigilance and Drug Safety Software Market Segment Analysis

Based on Functionality, the Adverse Event Reporting Software segment held the largest market share in 2025 and is expected to maintain its dominance during the forecast period. Pharmacovigilance systems are primarily designed to monitor and report adverse drug reactions (ADRs), which are essential for regulatory compliance and patient safety. Pharmaceutical companies increasingly rely on advanced adverse event reporting systems to collect, process, and analyze safety data across global clinical trials and post-marketing surveillance. Additionally, the rising number of drug approvals and increasing regulatory requirements from agencies such as the FDA and EMA are driving the demand for advanced pharmacovigilance reporting solutions.

Based on Delivery Mode, the Cloud-based segment dominates the market due to its scalability, cost efficiency, and real-time data management capabilities. Cloud-based pharmacovigilance software enables pharmaceutical companies and contract research organizations to access safety data across multiple regions and regulatory systems. The growing adoption of SaaS-based healthcare platforms and the need for centralized drug safety databases are further accelerating the demand for cloud deployment models.

Based on Component, the Software segment accounted for the largest share of the market in 2025. Software solutions play a crucial role in case processing, signal detection, and regulatory submission management. Pharmaceutical and biotechnology companies are increasingly adopting automated pharmacovigilance platforms that integrate artificial intelligence and advanced analytics to improve drug safety monitoring and reduce operational complexity.

Based on End User, the Pharmaceutical and Biotechnology Companies segment dominated the market owing to the increasing demand for efficient drug safety monitoring systems. These organizations are responsible for monitoring adverse drug reactions, maintaining regulatory compliance, and managing post-marketing drug surveillance. The growing number of clinical trials and expanding global pharmaceutical research activities are further contributing to the adoption of pharmacovigilance software solutions.

Global Pharmacovigilance and Drug Safety Software Market Regional Analysis

North America dominated the Global Pharmacovigilance and Drug Safety Software Market in 2025 and accounted for the largest market share of over 51%, driven by the strong presence of pharmaceutical companies, advanced healthcare IT infrastructure, and stringent drug safety regulations. The United States is the key contributor to the regional market due to increasing regulatory requirements for drug safety monitoring and the widespread adoption of digital pharmacovigilance platforms across pharmaceutical organizations.

Europe held the second-largest share of the market due to strong regulatory frameworks and increasing investments in pharmacovigilance activities. Countries such as Germany, the United Kingdom, and France are major contributors, supported by strict drug safety regulations and increasing pharmaceutical research and development activities.

Asia Pacific is expected to grow at the fastest CAGR during the forecast period owing to the expansion of pharmaceutical manufacturing, increasing clinical trials, and rising healthcare digitization across countries such as China, India, and Japan. The growing adoption of digital health technologies and favorable government initiatives are expected to further drive market growth in the region.

Recent Industry Developments (2025–2026)

Global Pharmacovigilance and Drug Safety Software Market Scope Table:

Market By Region :

North America (U.S., Canada, Mexico)
Europe (Germany, UK, France, Italy, Spain, Rest of Europe)
Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of Middle East & Africa)

Global Pharmacovigilance and Drug Safety Software Market Key Players:

1. Oracle Corporation
2. IQVIA Holdings Inc.
3. ArisGlobal LLC
4. Veeva Systems Inc.
5. SAS Institute Inc.
6. Accenture PLC
7. Cognizant Technology Solutions Corporation
8. Wipro Limited
9. Clarivate PLC
10. Ennov SAS
11. AB Cube SARL
12. Sarjen Systems Pvt. Ltd.
13. EXTEDO GmbH
14. Pegasystems Inc.
15. Honeywell International Inc.
16. Indegene Pvt. Ltd.
17. United BioSource LLC
18. TriNetX LLC
19. BaseCon AS
20. Max Application Srl
21. Genpact Limited
22. ICON plc
23. Parexel International Corporation
24. Ergomed Group
25. Quanticate International Ltd.